Sign up to our newsletter Subscribe

  • All Topics
  • Health Technology Assessment (HTA)
  • Antimicrobial Resistance (AMR)
OHE
Newsletter SignupSubscribe

Sign up to our newsletter Subscribe

  • All Topics
  • Health Technology Assessment (HTA)
  • Antimicrobial Resistance (AMR)
OHE
Newsletter SignupSubscribe

Close
OHE
  • Research & Publications
  • News & Insights
  • Education
  • Innovation Policy Prize
  • Events
  • About Us
  • OHE Experts
  • Join OHE
  • Contact Us
Newsletter SignupSubscribe

Research & Publications

All Publications

Filter by:
  • Antimicrobial Resistance (AMR)
  • Biosimilars
  • Cell and Gene Therapies
  • Chronic Diseases
  • Combination Therapies
  • COVID-19 Research
  • Digital Health
  • Drug Development/R&D
  • Emerging Markets
  • EQ-5D and PROMs
  • Indication-Based Pricing
  • Health Care Systems
  • Health Data and Statistics
  • Health Technology Assessment
  • Precision Medicine
  • Prevention
  • Real-World Evidence
  • Sustainability
  • Use of Medicines
  • Value-Based Pricing
  • Vaccine Research
  • Economics of Innovation
  • Measuring and Valuing Outcomes
  • Policy, Organisation and Incentives in Health Systems
  • Value, Affordability and Decision Making

News & Insights

  • News
  • Events
  • Insights
  • Bulletin

Education

  • Education Hub
  • OHE Graduate School
  • EVIA Programme

Innovation Policy Prize

  • The Prize Fund
  • 2024 Prize Fund
  • 2022 Prize Fund

Latest Research & Publications

  • Chronic Diseases
  • Policy, Organisation and…

Altering the Trajectory of HIV in Europe

Altering the trajectory of HIV-6
Read more
  • Chronic Diseases
  • Value, Affordability, and…

Understanding the Full Value of Long-Acting Therapies: less is more?

Understanding the Full Value of Long-Acting Therapies: less is more?
Read more
  • Health Technology Assessment…
  • Value, Affordability, and…

An Analysis of NICE’s Optimised Decisions from 2015 to 2024

An Analysis of NICE’s Optimised Decisions from 2015 to 2024
Read more
  • Health Care Systems
  • Policy, Organisation and…

Analysing Global Immunisation Expenditure

Analysing Global Immunisation Expenditure
Read more
  • Health Technology Assessment…
  • Value, Affordability, and…
  • Broader value and societal…

The BRAVER Roadmap to Broader Assessment of the Value of Health Interventions in the Asia-Pacific Region

The BRAVER Roadmap to Broader Assessment of the Value of Health Interventions in the Asia-Pacific Region
Read more
  • Cell and Gene Therapies
  • Value, Affordability, and…
  • Budget Impact Analysis

Challenges and Solutions for Budget Impact Analysis of Gene Therapies

Challanges and Solutions for Budget Impact Analysis of Gene Therapies
Read more
  • Drug Development/R&D
  • Economics of Innovation
  • Competition

The Importance of Diversity of Supply in Rare Diseases Markets

The Importance of Diversity of Supply in Rare Diseases Markets
Read more
© VK Studio at stock.adobe.com

2023 OHE Annual Report to the Charity Commission

Untitled v2
Read more
Close
OHE
  • All Publications

    Filter by:
    • Antimicrobial Resistance (AMR)
    • Biosimilars
    • Cell and Gene Therapies
    • Chronic Diseases
    • Combination Therapies
    • COVID-19 Research
    • Digital Health
    • Drug Development/R&D
    • Emerging Markets
    • EQ-5D and PROMs
    • Indication-Based Pricing
    • Health Care Systems
    • Health Data and Statistics
    • Health Technology Assessment
    • Precision Medicine
    • Prevention
    • Real-World Evidence
    • Sustainability
    • Use of Medicines
    • Value-Based Pricing
    • Vaccine Research
    • Economics of Innovation
    • Measuring and Valuing Outcomes
    • Policy, Organisation and Incentives in Health Systems
    • Value, Affordability and Decision Making
    • News
    • Events
    • Insights
    • Bulletin
    • Education Hub
    • OHE Graduate School
    • EVIA Programme
    • The Prize Fund
    • 2024 Prize Fund
    • 2022 Prize Fund
  • Events
  • About Us
  • OHE Experts
  • Join OHE
  • Contact Us
Newsletter SignupSubscribe
Back
  • Health Policy and Regulation
  • Martina Garau
< 1 min read|01/02/2007

Estimating Pharmaceutical Companies’ Value to the Nation: Case Study of the British Pharma Group

Read more
Martina 3
Martina Garau
Share:
  •  Twitter
  •  LinkedIn
  •  Facebook
  • has-icon Email
Download publication
Download Full Publication
  • Health Policy and Regulation
  • Martina Garau

Estimating Pharmaceutical Companies’ Value to the Nation: Case Study of the British Pharma Group

Estimating Pharmaceutical Companies’ Value to the Nation: Case Study of the British Pharma Group

Related Publications

  • Health Technology Assessment…
  • Value, Affordability, and…

How Have HTA Agencies Evolved Their Methods Over Time?

javier-allegue-barros-0nOP5iHVaZ8-unsplash-scaled-cropped
Read more
  • Prevention
  • Policy, Organisation and…
  • Cancer

The Socioeconomic Burden Of Cervical Cancer in the UK: What are the benefits of achieving the WHO elimination target?

The Socioeconomic Burden of Cervical Cancer in the UK: What are the Benefits of Achieving the WHO Elimination Target?
Read more
  • Biosimilars
  • Economics of Innovation
  • Generics

The Dynamics of Drug Shortages

The Dynamics of Drug Shortages
Read more
  • Health Technology Assessment…
  • Economics of Innovation
  • Innovation

Innovation for Health System Efficiency and Improvement

Innovation for Health System Efficiency and Improvement
Read more
footer_ohe_logo

Leading intellectual authority on global health economics

Sign Up for OHE Insights, Events & News Bulletin

Newsletter SignupStart Sign Up

Research & Publications

News & Insights

Innovation Policy Prize

Education

Events

About Us

OHE Experts

Contact Us

Sign Up for OHE Insights, Events & News Bulletin

Newsletter SignupStart Sign Up

The Office of Health Economics (OHE) is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at 2nd Floor Goldings House, Hay’s Galleria, 2 Hay’s Lane, London, SE1 2HB.

Terms & Conditions

Privacy Policy

Cookies Policy

© 2025 Website Design

An error has occurred, please try again later.

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

 Twitter
 Facebook
 LinkedIn
 Copy
 Email

Share on Mastodon

Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Please enable Strictly Necessary Cookies first so that we can save your preferences!